Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Wellcome Trust has awarded a two-year extension to the grant for our Wellcome Centre for Integrative Neuroimaging. This means that WIN is funded through to April 2024.

Group of researchers from Wellcome Centre for Integrative Neuroimaging

The Wellcome Centre for Integrative Neuroimaging (WIN) was established in 2017. It bridges the gap between laboratory neuroscience and human health, by performing multi-scale studies spanning from animal models through to human populations.

The extension is testament to the progress that WIN has demonstrated so far against its vision in all five of its themes: cross-species relationships; cross-scale integration; population data-mining; clinical neuroimaging and open neuroimaging.

WIN researchers have so far generated 698 peer-reviewed publications (and 152 preprints). These papers have collectively gathered 4807 citations to date.

The work of WIN staff has had an impact in many areas, including:

  • Clinical discovery (e.g. throuh the licensing of its software library (FSL) to non-academic users in clinical settings)
  • Clinical practice (e.g. establishing the ‘Brain Health Centre’, opening to memory clinic patients in spring 2020)
  • Engaging industry (e.g. hosting five industry-funded PhD students)
  • Scientific practice: (e.g. influencing neuroimaging research practice via FSL. The main FSL paper has been cited >9000 times).
  • Public debate (e.g. holding a day for patients and public on ‘Building better brain research’).

WIN has also had an impact more locally, initiating new collaborations and leveraging further funding. Fifty-three PhD students have completed since WIN began, and facilities have been enhanced (including the installation of a new rodent scanner and a new MEG scanner).

WIN has ensured that working practices reflect its values, including openness and inclusivity. For example, they have established working groups in Open Science and Equality, Diversity and Inclusion.

Core staff have been recruited, including Jason Lerch (heading up the small-animal imaging facility), Ben Seymour (Wellcome Clinical Research Fellow) and Madalena Fonseca (preclinical functional MRI).

The extension will allow WIN to establish incentives (e.g seed grants) and support (e.g facilitators) for projects that take mechanism to clinical population, or basic neuroscience to clinical translation. It will also provide resources to develop their cutting-edge work on building a positive research culture.

Similar stories

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

Two NDCN students join BNA Scholars Programme

The British Neuroscience Association Scholars Programme was launched in 2021 with a view to improving equality, diversity and inclusion in neuroscience.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ophthalmology Conference in Kyiv

On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.